Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) is adding two new members to its board of directors starting next year.
The New York-based cannabis producer announced Monday that Michelle Bodner and Shasheen Shah are joining the board. Bodner is an expert in operations, real estate and executive coaching. She has been an advisor to government agencies, banks, large corporations, non-profits and early and mid-stage companies in multiple industries.
Bodner has held multiple positions at Curaleaf including tenures as Board Member, first Chief Operating Officer, and the President and CEO of Curaleaf’s New York and Florida. She is a member of the advisory board of Treehouse Global Ventures and was named one of the 2019 CBD Power Women in Cannabis.
“I am thrilled to welcome Michelle and Shasheen to the Curaleaf board of directors to deepen our bench and add talent to our board, as we further develop governance,” Executive Chairman Boris Jordan said.
“Michelle is a seasoned entrepreneur and savvy advisor in the financial services, government, real estate and cannabis spaces and delivered impressive results for Curaleaf in our early days. She will be a valued and strategic voice as we move into our 2023 plan and beyond,” Jordan said.
Shah is Curaleaf’s fourth independent director and is the CEO of Coherent Strategies Consulting and Coaching which is a leadership development coach and advisor to global executives and organizations. He has worked with executives at Credit Suisse, Goldman Sachs, Barclays, Tesla, ButcherBox, and LinkedIn.
“Shasheen is a talented executive coach and progressive thinker who has delivered breakthrough results to global business leaders for 20 years.” Jordan added.
“I know that his business insights, approach to leadership culture and unique perspective will be instrumental in guiding the board and our company forward in its next evolution of growth.”
Shah and Bodner were appointed by the Board of Directors to serve until the next annual general shareholders meeting.
Curaleaf currently operates in 21 states with 144 dispensaries and 29 cultivation sites.
Curaleaf stock went down by 18.75 per cent on Monday to $5.85 on the Canadian Securities Exchange.